Abstract:Protein drugs are of great importance in maintaining the normal functioning of living organisms. Indeed, they have been instrumental in combating tumors and genetic diseases for decades. Among these pharmaceutical agents, those that target intracellular components necessitate the use of therapeutic proteins to exert their effects within the targeted cells. However, the use of protein drugs is limited by their short half-life and potential adverse effects in the physiological environment. The advent of nanoparticles offers a promising avenue for prolonging the half-life of protein drugs. This is achieved by encapsulating proteins, thereby safeguarding their biological activity and ensuring precise delivery into cells. This nanomaterial-based intracellular protein drug delivery system mitigates the rapid hydrolysis and unwarranted diffusion of proteins, thereby minimizing potential side effects and circumventing the limitations inherent in traditional techniques like electroporation. This review examines established protein drug delivery systems, including those based on polymers, liposomes, and protein nanoparticles. We delve into the operational principles and transport mechanisms of nanocarriers, discussing the various considerations essential for designing cutting-edge delivery platforms. Additionally, we investigate innovative designs and applications of traditional cytosolic protein delivery systems in medical research and clinical practice, particularly in areas like tumor treatment, gene editing and fluorescence imaging. This review sheds light on the current restrictions of protein delivery systems and anticipates future research avenues, aiming to foster the continued advancement in this field.

Nanoparticles: Oral Delivery for Protein and Peptide Drugs

Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability

Nano and Microscale Delivery Platforms for Enhanced Oral Peptide/protein Bioavailability.

Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies

Research Progress in Protein-Based Nanoparticle Drug Delivery System for Oral Administration

Progress in the Study of Oral Delivery of Protein and Peptide Drugs

Enhanced oral bioavailability from food protein nanoparticles: A mini review

Biopolymer Based Nano-Delivery Systems for Enhancing Bioavailability of Nutraceuticals

Recent Advances in Oral and Transdermal Protein Delivery Systems

Challenges and opportunities in delivering oral peptides and proteins

Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides

Protein Nanoparticles: Promising Platforms for Drug Delivery Applications

The Application of Nano Drugdelivery Systems in Protein Drugs

Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability

Application of Lipid Nanoparticles As Oral Drug Delivery System

Oral delivery of proteins and peptides: Challenges, status quo and future perspectives

Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome Both the Diffusion and Absorption Barriers

Nanocarriers for intracellular delivery of proteins in biomedical applications: strategies and recent advances

Nanotechnology for Protein Delivery: Overview and Perspectives.

Protein-Based Nanoparticles as Drug Delivery Systems

Nanoparticle oral absorption and its clinical translational potential